A Synthetic Receptor Enables Breakthrough Scale Manufacturing of iPSC-Derived CD19-CAR Cell Therapies for Hematologic and Autoimmune Diseases
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Dillon Jarrell, David Vereide, Cassidy Arnold, Max Murphey, Ashley Yingst, Ryan Koning, Nikole Perdue, Artem Romanov, Celeste Busch, Igor Slukvin, Ryan Crisman, Ryan P. Larson, Andrew M. Scharenberg, Branden Salinas, Samantha Ohara
Institution: University of Wisconsin–Madison
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405043679
